BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,696,225 | -17.8% | 557,969 | -11.0% | 0.00% | 0.0% |
Q2 2023 | $2,063,610 | -54.3% | 627,237 | -55.8% | 0.00% | -66.7% |
Q1 2023 | $4,512,318 | +11.9% | 1,418,968 | +143.4% | 0.00% | 0.0% |
Q4 2022 | $4,033,467 | -33.5% | 582,871 | -39.2% | 0.00% | -25.0% |
Q3 2022 | $6,066,000 | +12032.0% | 958,408 | +7810.3% | 0.00% | – |
Q2 2022 | $50,000 | -94.6% | 12,116 | -93.6% | 0.00% | -100.0% |
Q1 2022 | $919,000 | -81.9% | 189,497 | -62.7% | 0.00% | -66.7% |
Q4 2021 | $5,070,000 | +78.1% | 507,458 | +240.7% | 0.00% | +50.0% |
Q3 2021 | $2,847,000 | -48.5% | 148,964 | -13.9% | 0.00% | -33.3% |
Q2 2021 | $5,533,000 | +8.2% | 173,015 | +2.0% | 0.00% | 0.0% |
Q1 2021 | $5,113,000 | -37.7% | 169,570 | -10.6% | 0.00% | -40.0% |
Q4 2020 | $8,205,000 | -23.8% | 189,626 | -4.9% | 0.01% | -28.6% |
Q3 2020 | $10,763,000 | -5.7% | 199,500 | +6.7% | 0.01% | -22.2% |
Q2 2020 | $11,415,000 | +39.3% | 187,018 | +4.9% | 0.01% | +12.5% |
Q1 2020 | $8,197,000 | -40.2% | 178,357 | +14.3% | 0.01% | -20.0% |
Q4 2019 | $13,696,000 | -12.2% | 156,082 | -8.1% | 0.01% | -16.7% |
Q3 2019 | $15,599,000 | -39.8% | 169,898 | -16.6% | 0.01% | -42.9% |
Q2 2019 | $25,907,000 | +39.5% | 203,682 | +72.6% | 0.02% | +16.7% |
Q1 2019 | $18,565,000 | +21.1% | 118,002 | -23.6% | 0.02% | +12.5% |
Q4 2018 | $15,324,000 | -46.7% | 154,482 | -21.5% | 0.02% | -38.5% |
Q3 2018 | $28,724,000 | -55.7% | 196,746 | -52.3% | 0.03% | -55.9% |
Q2 2018 | $64,786,000 | +184.3% | 412,785 | +209.3% | 0.06% | +227.8% |
Q1 2018 | $22,786,000 | -42.8% | 133,453 | -40.4% | 0.02% | -43.8% |
Q4 2017 | $39,852,000 | +111.2% | 223,760 | +62.9% | 0.03% | +100.0% |
Q3 2017 | $18,866,000 | +32.6% | 137,352 | +1.4% | 0.02% | +23.1% |
Q2 2017 | $14,230,000 | +60.5% | 135,470 | +38.9% | 0.01% | +62.5% |
Q1 2017 | $8,865,000 | -9.7% | 97,528 | -38.7% | 0.01% | -11.1% |
Q4 2016 | $9,820,000 | -18.1% | 159,140 | -10.1% | 0.01% | -10.0% |
Q3 2016 | $11,997,000 | +57.9% | 176,988 | +0.9% | 0.01% | +25.0% |
Q2 2016 | $7,596,000 | +33.6% | 175,466 | +31.2% | 0.01% | +33.3% |
Q1 2016 | $5,685,000 | -41.5% | 133,771 | -11.6% | 0.01% | -40.0% |
Q4 2015 | $9,720,000 | +5.1% | 151,350 | +40.0% | 0.01% | +11.1% |
Q3 2015 | $9,249,000 | -21.0% | 108,102 | +55.6% | 0.01% | -10.0% |
Q2 2015 | $11,702,000 | +1042.8% | 69,496 | +718.5% | 0.01% | +900.0% |
Q1 2015 | $1,024,000 | +1.1% | 8,491 | -23.0% | 0.00% | 0.0% |
Q4 2014 | $1,013,000 | +3651.9% | 11,034 | +1357.6% | 0.00% | – |
Q3 2014 | $27,000 | -40.0% | 757 | -34.8% | 0.00% | – |
Q2 2014 | $45,000 | -55.9% | 1,161 | -74.0% | 0.00% | – |
Q1 2014 | $102,000 | -1.9% | 4,457 | -10.6% | 0.00% | – |
Q4 2013 | $104,000 | +1200.0% | 4,986 | +1567.6% | 0.00% | – |
Q3 2013 | $8,000 | – | 299 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |